by Admin | March 9, 2012 2:00 pm
March 9, 2012—The Health Resources and Services Administration (HRSA) has posted a document[1] on the Office of Pharmacy Affairs (OPA) Web site clarifying its policy on 340B covered entity audits.
The March 5 document, called a policy release, notes that the 340B statute permits the federal government and drug manufacturers to audit covered entity records pertaining to entities’ compliance with the prohibitions against drug diversion and duplicate discounts.
Source URL: https://340binformed.org/2012/03/hrsa-issues-policy-release-on-340b-audits/
Copyright ©2026 340binformed.org unless otherwise noted.